Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020223626 - SYSTEMS AND METHODS FOR RATIOMETRIC AND MULTIPLEXED ISOTHERMAL AMPLIFICATION OF NUCLEIC ACIDS

Note: Text based on automatic Optical Character Recognition processes. Please use the PDF version for legal matters

[ EN ]

CLAIMS:

1. A method for ratiometric amplification of specific nucleic acids, comprising:

obtaining or having obtained a sample, wherein the sample contains nucleic acids; and

performing an amplification reaction on the sample to amplify one or more target sequences in the sample by:

combining the sample with reaction components, wherein the reaction components comprise at least one target specific primer, nucleotides, and at least one polymerase, and

incubating the sample and the reaction components.

2. The method of claim 1 , wherein the incubating step is performed isothermally.

3. The method of claim 1 , wherein the incubating step is performed with an initial heating step, then incubated isothermally.

4. The method of claim 1 , further comprising analyzing an output of the amplification reaction.

5. The method of claim 4, wherein the analyzing step is performed using a fluorescence assay.

6. The method of claim 4, further comprising analyzing an output of the amplification reaction to identify one or more target sequences.

7. The method of claim 4, wherein the analyzing step is performed using electrophoresis.

8. The method of claim 7, wherein the electrophoresis is selected from the group consisting of gel electrophoresis and capillary electrophoresis.

9. The method of claim 7, wherein the electrophoresis is capable of quantitatively analyzing the output components.

10. The method of claim 1 , wherein the amplification reaction is selected from the group consisting of: nucleic acid sequence based amplification (NASBA), Loop-mediated isothermal amplification, Recombinase Polymerase Amplification, Rolling Circle Amplification, and Nicking Enzyme Amplification Reaction.

1 1 . The method of claim 4, wherein the analyzing step includes diagnosing an individual for a disease or disease state.

12. The method of claim 1 1 , wherein the disease or disease state is selected from the group consisting of HIV, tuberculosis, and sepsis.

13. The method of claim 1 , wherein the reaction components comprise dNTPs, NTPs, a buffer, at least one primer, and a transcriptase.

14. The method of claim 13, wherein the components further include a reverse transcriptase.

15. The method of claim 13, wherein the transcriptase is an RNA polymerase.

16. The method of claim 13, wherein the components further include a nuclease.

17. The method of claim 16, wherein the nuclease is RNase H.

18. The method of claim 13, wherein the dNTPs are a limiting reagent in the reaction to maintain ratiometric amplification of the template nucleic acids in the sample.

19. The method of claim 18, wherein the dNTP concentration is no greater than 1/5X concentration for a standard amplification reaction.

20. The method of claim 1 , wherein the biological sample is selected from the group consisting of saliva, urine, and blood.